Texas Yale Capital Corp. Eli Lilly & CO Transaction History

Texas Yale Capital Corp.

$2.28 Billion
Q3 2024

A detailed history of Texas Yale Capital Corp. transactions in Eli Lilly & CO stock. As of the latest transaction made, Texas Yale Capital Corp. holds 6,720 shares of LLY stock, worth $5.04 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

6,720

Previous 6,750 0.44%

Holding current value

$5.04 Million

Previous $6.11 Million 2.59%

% of portfolio

0.26%

Previous 0.29%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $23,164 - $28,800	-30 Reduced 0.44%	6,720 $5.95 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $85,534 - $107,266	118 Added 1.78%	6,750 $6.11 Million
Q1 2024 May 08, 2024	BUY	$592.2 - $792.28 $20,134 - $26,937	34 Added 0.52%	6,632 $5.16 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $581,910 - $685,996	1,108 Added 20.18%	6,598 $3.85 Million
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $1.31 Million - $1.8 Million	-3,008 Reduced 35.4%	5,490 $2.95 Million
Q2 2023 Aug 03, 2023	SELL	$350.74 - $468.98 $38,932 - $52,056	-111 Reduced 1.29%	8,498 $3.99 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $2,250 - $2,622	7 Added 0.08%	8,609 $3.15 Million
Q3 2022 Nov 08, 2022	SELL	$296.48 - $337.87 $112,662 - $128,390	-380 Reduced 4.23%	8,602 $2.78 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $21,183 - $24,872	76 Added 0.85%	8,982 $2.91 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $36,200 - $44,925	161 Added 1.84%	8,906 $2.46 Million
Q3 2021 Nov 08, 2021	BUY	$221.6 - $272.71 $221 - $272	1 Added 0.01%	8,745 $2.02 Million
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $8,051 - $10,423	-49 Reduced 0.56%	8,744 $1.63 Million
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $130 - $172	1 Added 0.01%	8,793 $1.49 Million
Q3 2020 Nov 10, 2020	SELL	$146.22 - $169.13 $15,353 - $17,758	-105 Reduced 1.18%	8,792 $1.3 Million
Q2 2020 Jul 31, 2020	SELL	$136.42 - $164.18 $357,966 - $430,808	-2,624 Reduced 22.78%	8,897 $1.46 Million
Q1 2020 May 13, 2020	BUY	$119.05 - $147.35 $119 - $147	1 Added 0.01%	11,521 $1.6 Million
Q2 2019 Jul 24, 2019	SELL	$110.79 - $129.32 $1.28 Million - $1.49 Million	-11,520 Reduced 50.0%	11,520 $1.28 Million
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $1.28 Million - $1.51 Million	11,520 Added 100.0%	23,040 $2.99 Million
Q4 2018 Feb 11, 2019	SELL	$105.9 - $118.64 $9,001 - $10,084	-85 Reduced 0.73%	11,520 $1.33 Million
Q2 2018 Aug 07, 2018	SELL	$75.7 - $86.88 $132,853 - $152,474	-1,755 Reduced 13.14%	11,605 $990,000
Q1 2018 May 03, 2018	SELL	$74.21 - $87.6 $7,792 - $9,198	-105 Reduced 0.78%	13,360 $1.03 Million
Q4 2017 Feb 07, 2018	BUY	$81.94 - $87.89 $49,573 - $53,173	605 Added 4.7%	13,465 $1.14 Million
Q3 2017 Nov 08, 2017	BUY	$77.07 - $85.54 $991,120 - $1.1 Million	12,860	12,860 $1.1 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Yale Capital Corp., based on Form 13F filings with the SEC.

News

Stay updated on Texas Yale Capital Corp. with notifications on news.

Account

Texas Yale Capital Corp. Eli Lilly & CO Transaction History